Diagnosis and Management of Generalized Anxiety Disorder

	Tweet

Treatment Duration

The duration of treatment of GAD is uncertain. Several authors have suggested that patients be treated with the lowest effective dose and re-evaluated for medication discontinuance at 6-month intervals.

Approximately 50% of patients successfully treated with either clorazepate or Buspirone will relapse upon drug discontinuation at 6 months. 

This indicates that about one-half of GAD patients can benefit from short-term treatment, while the rest require more prolonged therapy. However, patients treated with benzodiazepines have twice the recurrence of anxiety symptoms or need further antianxiety treatment than do those treated with nonbenzodiazepine medications. Some experts suggest that medications that do not produce euphoria and sedation, such as Buspirone or antidepressants, may allow the patient to make more progress in coping skills and anxiety-management behavior than with benzodiazepines.

--------------------------------------------------------
Welcome to our Online Pharmacy

The online prescription medication store you can trust. » »
---------------------------------------------------------

RELATED STORIES:
Depression Treatment   Is It Clinical Depression or Sadness?   First Person Description of Major Depression   Selective Serotonin Reuptake Inhibitors (SSRI)   What Happens in the Depressed Brain?   Antidepressant Classes   Learn About Depression and Anxiety Disorders   Antidepressant Medication during Pregnancy & Postpartum   Don’t Stop Taking Your Antidepressants   Treatment of Major Depression   Major Depression in Children and Adolescents   Major Depression (Clinical Depression)

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]